Real-world evidence of reduced disability costs during the Finnish Allergy Programme 2008-2018.

Jantunen, Juha; Kauppi, Paula; Linna, Miika; Mäkelä, Mika; Pelkonen, Anna; Haahtela, Tari

Jantunen, Juha; Kauppi, Paula; Linna, Miika; Mäkelä, Mika; Pelkonen, Anna; Haahtela, Tari.

Afiliação

Jantunen J; Allergy, Skin and Asthma Federation, Helsinki, Finland.
Kauppi P; Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Linna M; Healthcare Engineering, Management and Architecture Institute, Aalto University, Espoo, Finland.
Mäkelä M; Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Pelkonen A; Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Haahtela T; Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Allergy ; 76(12): 3817-3819, 2021 12.

Article em En | MEDLINE | ID: mdl-34460940

Assuntos

Asma; Hipersensibilidade; Finlândia/epidemiologia; Humanos; Hipersensibilidade/epidemiologia; Hipersensibilidade/terapia

Palavras-chave

allergy treatment; asthma; asthma treatment; prevention

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Asma / Hipersensibilidade Tipo de estudo: Health_economic_evaluation Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Allergy Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google